{
  "resourceType": "ConditionDefinition",
  "id": "example",
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative: ConditionDefinition\u003c/b\u003e\u003ca name\u003d\"example\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource ConditionDefinition \u0026quot;example\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003eurl\u003c/b\u003e: \u003ccode\u003ehttp://hl7.org/fhir/ConditionDefinition/example\u003c/code\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003eidentifier\u003c/b\u003e: id: urn:oid:2.16.840.1.113883.4.642.25.1\u003c/p\u003e\u003cp\u003e\u003cb\u003ename\u003c/b\u003e: Hyperlipidemia\u003c/p\u003e\u003cp\u003e\u003cb\u003etitle\u003c/b\u003e: Hyperlipidemia Status\u003c/p\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: draft\u003c/p\u003e\u003cp\u003e\u003cb\u003edate\u003c/b\u003e: 2019-05-26T10:44:00+10:00\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: Hyperlipidemia (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#55822004)\u003c/span\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ehasSeverity\u003c/b\u003e: false\u003c/p\u003e\u003cp\u003e\u003cb\u003ehasBodySite\u003c/b\u003e: false\u003c/p\u003e\u003cp\u003e\u003cb\u003ehasStage\u003c/b\u003e: false\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinition\u003c/b\u003e: \u003ca href\u003d\"https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf\"\u003ehttps://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf\u003c/a\u003e\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003eobservation\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: Lipid Panel \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#24331-1 \u0026quot;Lipid 1996 panel - Serum or Plasma\u0026quot;)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003eobservation\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: Cholesterol \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#35200-5 \u0026quot;Cholesterol [Moles/​volume] in Serum or Plasma\u0026quot;)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003eobservation\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: Triglyceride \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#35217-9 \u0026quot;Triglyceride [Moles/​volume] in Serum or Plasma\u0026quot;)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003eobservation\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: Cholesterol in HDL \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#2085-9 \u0026quot;HDL Cholesterol\u0026quot;)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003eobservation\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: LDL Chol. (Calc) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#13457-7 \u0026quot;Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation\u0026quot;)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003ch3\u003eMedications\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eCode\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eGemfibrozil \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"http://terminology.hl7.org/4.0.0/CodeSystem-v3-rxNorm.html\"\u003eRxNorm\u003c/a\u003e#203151)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003ePlans\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eReference\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003e\u003ca href\u003d\"broken-link.html\"\u003ehttp://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6\u003c/a\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/div\u003e"
  },
  "url": "http://hl7.org/fhir/ConditionDefinition/example",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.4.642.25.1"
    }
  ],
  "name": "Hyperlipidemia",
  "title": "Hyperlipidemia Status",
  "status": "draft",
  "date": "2019-05-26T10:44:00+10:00",
  "code": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "55822004",
        "display": "Hyperlipidemia (disorder)"
      }
    ]
  },
  "hasSeverity": false,
  "hasBodySite": false,
  "hasStage": false,
  "definition": [
    "https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"
  ],
  "observation": [
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24331-1",
            "display": "Lipid 1996 panel - Serum or Plasma"
          }
        ],
        "text": "Lipid Panel"
      }
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "35200-5",
            "display": "Cholesterol [Moles/​volume] in Serum or Plasma"
          }
        ],
        "text": "Cholesterol"
      }
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "35217-9",
            "display": "Triglyceride [Moles/​volume] in Serum or Plasma"
          }
        ],
        "text": "Triglyceride"
      }
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "HDL Cholesterol"
          }
        ],
        "text": "Cholesterol in HDL"
      }
    },
    {
      "code": {
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"
          }
        ],
        "text": "LDL Chol. (Calc)"
      }
    }
  ],
  "medication": [
    {
      "code": {
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "203151",
            "display": "Gemfibrozil"
          }
        ]
      }
    }
  ],
  "plan": [
    {
      "reference": {
        "reference": "http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"
      }
    }
  ]
}